Research Triangle Park, North Carolina-based Teleflex Medical has announced their acquisition of Tel Aviv-based Eon Surgical, Ltd., a late stage development company that has advanced a minimally invasive microlaparoscopy surgical platform technology designed to enhance surgeons’ ability to perform scar-less surgery while producing better patient outcomes. Eon Surgical is a portfolio company of the RAD Biomed Accelerator, and the purchase price of “a few tens of millions of dollars” was reported by Globes.
“This acquisition is consistent with our focus on innovative technologies and will greatly expand Teleflex’s offerings that address the significant market opportunity for minimally invasive laparoscopic procedures,” said Benson Smith, Chairman, President and CEO.
Commenting on the acquisition, Danny Farin, CEO and co-founder of Eon Surgical, stated, “We are proud to be associated with a prestigious industry partner like Teleflex. This is a wonderful opportunity to accelerate the global expansion of our innovative platform, while providing the highest level of support to surgeons throughout the world. I am very thankful for the opportunity to work with Eon’s synergistic, highly skillful and professional team.”
David Zigdon, CEO of RAD BioMed, Eon Surgical’s accelerator, added, “Eon Surgical achieved extraordinary results in a remarkably short period of time due to diligent and inspiring work that brought a novel concept from inception to market in three years.